CIPLA - Technical Analysis
Last Updated Time : 02 Aug 25, 12:58 am
Back to Technical List📊 Technical Analysis Summary for CIPLA
Technical Rating: 4.2
📈 Trend Status & Chart Patterns
Trend Status: The stock is currently trending upward, supported by strong momentum and a breakout above key resistance.
Pattern Observed: A Cup and Handle breakout on the weekly chart confirms bullish continuation. Price action is forming higher highs and higher lows.
Price Action: Trading near its 52-week high with strong bullish candles and volume confirmation.
📉 Moving Averages
50 DMA: ₹1,499 — Current price is above, indicating short-term bullishness.
200 DMA: ₹1,488 — Also above, confirming long-term uptrend.
Signal: All major moving averages are sloping upward, reinforcing strength.
📊 RSI & MACD
RSI: 71.1 — In overbought zone, but consistent with strong uptrend.
MACD: +10.3 — Positive and above signal line, confirming bullish momentum.
Signal: Momentum is strong; minor pullbacks may occur but trend remains intact.
📉 Bollinger Bands
Price is near the upper band, suggesting strong buying pressure.
Signal: May consolidate or pull back slightly before next leg up.
🔊 Volume Trends
Current Volume: 13.3 lakh vs 1-week Avg: 27.2 lakh — Below average, indicating reduced participation.
Signal: Volume contraction during uptrend suggests healthy consolidation, not weakness.
📌 Support & Resistance Zones
Level Price (₹) Commentary
Support 1 1,525 Recent breakout zone
Support 2 1,488 200 DMA, strong long-term support
Resistance 1 1,600 Psychological level
Resistance 2 1,702 52-week high
🎯 Entry & Exit Zones
Optimal Entry: ₹1,525–₹1,540 (on pullback near support)
Exit Target: ₹1,675–₹1,700 (if momentum sustains)
Stop-Loss: ₹1,485 (below 200 DMA)
🧭 Final Take
CIPLA is in a strong bullish trend with momentum indicators and moving averages aligned positively. While RSI suggests short-term overbought conditions, the overall setup favors continuation. Traders may consider buying on dips near ₹1,525 with a target toward ₹1,700.
Want to explore how it stacks up against other pharma stocks or dive into its fundamentals next?
Edit in a page
Back to Technical List